SCHEMBL6350083

SCHEMBL6350083

N#Cc1ccc(NC(=O)c2ccc(Oc3ccccc3)cc2)c(C(=O)O)c1

nearest known ligand 0.68

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SERPINE1 P05121 1/20 0.68
ALB P02768 1/20 0.54
MAPT P10636 1/20 0.52
NR1H4 Q96RI1 2/20 0.52
IGF2BP2 Q9Y6M1 1/20 0.52
KMT2A Q03164 3/20 0.51
MEN1 O00255 2/20 0.51
NPC1 O15118 1/20 0.51
RAB9A P51151 1/20 0.51
SMN1; SMN2 Q16637 1/20 0.51
F2 P00734 1/20 0.50
PLG P00747 1/20 0.50
PLAU P00749 1/20 0.50
KLKB1 P03952 1/20 0.50
PRSS1 P07477 1/20 0.50
HDAC1 Q13547 1/20 0.49
HDAC8 Q9BY41 1/20 0.49
HDAC6 Q9UBN7 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6349507 0.92 MEN1 (0.57) SERPINE1KMT2AMEN1NPC1RAB9A
SCHEMBL6353963 0.88 KMT2A (0.62) SERPINE1ALBMAPTKMT2AMEN1
SCHEMBL2290656 0.88 MEN1 (0.63) SERPINE1KMT2AMEN1NPC1RAB9A
SCHEMBL6821355 0.88 SERPINE1 (0.53) SERPINE1ALBKMT2AMEN1
SCHEMBL14075343 0.87 SERPINE1 (0.58) SERPINE1MAPTNR1H4IGF2BP2KMT2A
SCHEMBL6359401 0.87 ALB (0.63) SERPINE1ALBMAPTKMT2AMEN1
SCHEMBL6349721 0.87 MEN1 (0.57) SERPINE1MAPTKMT2AMEN1NPC1
SCHEMBL6359657 0.86 MAPT (0.70) SERPINE1ALBMAPTKMT2AMEN1
SCHEMBL6349987 0.86 ALB (0.57) SERPINE1ALBMAPTNR1H4IGF2BP2
SCHEMBL6348677 0.86 SERPINE1 (0.66) SERPINE1ALBMAPTIGF2BP2KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050113450-A1 Antibacterial agents PHARMACIA & UPJOHN COMPANY 2005-05-26 US claimed
WO-2004018414-A2 ANTIBACTERIAL AGENTS PHARMACIA & UPJOHN COMPANY LLC (US) 2004-03-04 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050113450-A1 Antibacterial agents CLPP, SPOUT1, SAMHD1 SERPINE1 1929/4885ALB 1682/4885MAPT 4753/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.